Cancer of the Larynx Clinical Trial
Official title:
Phase II Trial Evaluating Elimination of Radiation Therapy To Pathological N0 Neck(s) With Intensity Modulated Postoperative Radiation Therapy
The purpose of this study is to determine if reducing or eliminating radiation treatment to one or both sides of the neck where there is no evidence of cancer can help spare the side effects of radiation treatment for head and neck cancer. In this study, the investigators plan to reduce the amount of radiation treatment received to healthy tissue
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00117572 -
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
|
Phase 3 | |
Not yet recruiting |
NCT01607138 -
Speech and Swallowing Characteristics of Patients After Laryngectomy and the Effect on Quality of Life
|
N/A | |
Recruiting |
NCT00970502 -
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT00462735 -
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
|
Phase 2 |